• Blog
  • Human Microbiome Market Analysis | 2021-2026

    Human Microbiome Market Analysis | 2021-2026

    Human Microbiome Market Analysis | 2021-2026
    Report code - SRHL245 Delivery - 2 Weeks
    Human Microbiome Market Size, Share, Forecast & Competitive Analysis: 2021-2026
    See more...

    Market Insights

    The Human Microbiome Market was estimated at US$ 520.5 million in 2020 and is expected to grow at an impressive CAGR of 23.2% during 2021-2026 to reach US$ 1783.9 million by 2026. 


    Wish to get a free sample? Register Here

    What are Human Microbiomes?

    Human microbiomes are intricate communities of microorganisms, including bacteria, viruses, fungi, and other microbes, that inhabit various parts of the human body, such as the skin, mouth, gut, and reproductive organs. These microorganisms play a vital role in maintaining human health by contributing to digestion, nutrient absorption, immune system regulation, and even influencing mental well-being.

    The composition and balance of these microbiomes can be influenced by factors like diet, environment, genetics, and medical interventions. Studying human microbiomes is a growing field in understanding their impact on overall health and exploring potential therapeutic applications.

    Market Dynamics

    The growing prevalence of C. Difficile infection (CDI) is a key factor driving the demand for human microbiomes.

    • Furthermore, the introduction of probiotics is expected to bring change in intestinal microbiota and can stabilize microbial communities, thus can prevent gut inflammation, and boosting the growth of the human microbiome market.

    • Moreover, rising collaborations between public and private organizations offer immense opportunities to market players. However, government regulations are expected to restrain product consumption in the following years.

    COVID-19 Impact

    The COVID-19 pandemic has adversely affected the human microbiome industry including the preclinical studies and clinical trials of microbiome-based therapeutics and diagnostics products. Furthermore, the COVID-19 pandemic has focused on the need for manufacturing companies and R&D organizations to collaborate with the government to innovate therapeutics and diagnostics, to meet future health crises. Several universities and major market players are focusing on developing interventions for coronavirus.

    Segments Analysis

    Application Trends

    The global human microbiome market has been bifurcated into therapeutics and diagnostics.

    • Under these, the therapeutics segment held the largest market share and is likely to register a substantial CAGR in the following years.

    • This is mainly attributed to an increase in R&D funding for microbiome-based therapies and technological advancements, which promulgates segment growth.

    Regional Analysis

    The North American market garnered the highest market share and is projected to grow at a healthy CAGR during the assessment period.

    • This is mainly attributed to the increasing incidences of lifestyle-related diseases and autoimmune disorders in this region.

    • Also, the presence of a strong drug pipeline further boosts regional growth.

    • The US is the largest contributor to regional market growth due to the increasing standard of living and high medical expenditure.

    Want to know which region offers the best growth opportunities? Register Here

    Key Players

    The key players operating in the global human microbiome market are

    • DuPont de Nemours, Inc. (The U.S),
    • ENTEROME (France),
    • Merck Sharp & Dohme Corp (The U.S),
    • Metabiomics Corporation (The U.S),
    • Osel, Inc. (The U.S),
    • Second Genome Inc. (The U.S),
    • Seres Therapeutics (The U.S), and
    • Synthetic Biologics, Inc. (The U.S).
    • Vedanta Biosciences, Inc. (The U.S),
    • ViThera Pharmaceuticals, Inc. (The U.S),
    • Yakult (Japan).

    Target Audience

    The following is a list of the customers that the human microbiome market aims to convert the most:

    • Companies
    • Vendors
    • R&D Organizations
    • Hospitals
    • Government Organizations

    Critical Questions Answered in the Report

    • What are the key trends in the global human microbiome market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global human microbiome market?
    • What are the key strategies adopted by the major vendors to lead in the global human microbiome market?
    • What is the market share of the top vendors?

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data. We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

    Report Features

    This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth Analysis of the Human Microbiome Market 

    How lucrative is the future?

    The market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market segment analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

    Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players).
    • SWOT analysis of key players (up to three players).

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: product portfolio, geographical reach, regional presence, and strategic alliances.

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@Stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The Global Human Microbiome Market is projected to grow at a CAGR of over 23.2% during the forecast period.

    ENTEROME (France), Yakult (Japan), DuPont de Nemours, Inc. (The U.S), Metabiomics Corporation (The U.S), ViThera Pharmaceuticals, Inc. (The U.S), Second Genome Inc. (The U.S), MICROBIOME THERAPEUTICS LLC (The U.S), Vedanta Biosciences, Inc. (The U.S), Osel, Inc. (The U.S), Merck Sharp & Dohme Corp (The U.S), Seres Therapeutics (The U.S) and Synthetic Biologics, Inc. (The U.S) are among the key players in the human microbiome market.

    The Human Microbiome Market is expected to reach US$ 1783.9 million by 2026.

    North America garnered the largest share of the human microbiome market during the forecast period.

    The therapeutics segment held the largest share of the human microbiome market during the forecast period.

    Human microbiome companies, Human microbiome vendors, R&D organizations, Hospitals, and Government organizations are the target audience in the human microbiome market.